Redmile Group, LLC 13D/13G Filings for RAPT Therapeutics, Inc. (RAPT)

Redmile Group, LLC 13D and 13G filings for RAPT Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-08-14
4:18 pm
Purchase
2025-06-3013GRAPT Therapeutics, Inc.
RAPT
Redmile Group, LLC1,765,303
9.900%
1,765,303increase
(New Position)
Filing